Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Operating Leases (2023 - 2025)

BrightSpring Health Services' Operating Leases history spans 3 years, with the latest figure at $135.4 million for Q4 2025.

  • For Q4 2025, Operating Leases rose 4.6% year-over-year to $135.4 million; the TTM value through Dec 2025 reached $135.4 million, up 4.6%, while the annual FY2025 figure was $135.4 million, 4.6% up from the prior year.
  • Operating Leases reached $135.4 million in Q4 2025 per BTSG's latest filing, up from $128.8 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $208.2 million in Q1 2024 to a low of $128.8 million in Q3 2025.
  • Average Operating Leases over 3 years is $162.0 million, with a median of $135.4 million recorded in 2025.
  • The largest YoY upside for Operating Leases was 4.6% in 2025 against a maximum downside of 37.4% in 2025.
  • A 3-year view of Operating Leases shows it stood at $201.7 million in 2023, then plummeted by 35.8% to $129.5 million in 2024, then rose by 4.6% to $135.4 million in 2025.
  • Per Business Quant, the three most recent readings for BTSG's Operating Leases are $135.4 million (Q4 2025), $128.8 million (Q3 2025), and $132.5 million (Q2 2025).